“… Human embryonic stem cell research currently presents unprecedented public policy and regulatory challenges, with the therapies derived from hESCR having the potential to deeply affect lives but it has become an area of bioethical and public policy controversy across the world …” (report)
[Irish Stem Cell Foundation, 28 April]